Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04024631 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phenotyping Genetic Risk for Type 2 Diabetes

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from University of Pennsylvania

Record History

  1. Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2027 Eligibility criteria expanded, about 13 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 13 words
  2. Site contacts updated at 2 of 2 sitesv7
  3. Primary and study completion dates: Jun 30, 2024 to Jun 30, 2026v6
  4. Primary and study completion dates: Jun 30, 2023 to Jun 30, 2024v5
  5. 2 versions Re-verified since Aug 21, 2020, no change to tracked fieldsv3-v4
  6. Secondary endpoints revised (3)v2 See this version in full on ClinicalTrials.gov ↗
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.
Trial Details
NCT Number NCT04024631
Lead Sponsor University of Pennsylvania
Conditions Diabetes Mellitus, Type 2, Genetics
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov